Emergent Biosolutions(EBS-N)NYSE
Today's Change
Real-Time Last Update
Pre Market Change
Pre Market Last Update
Volume
Current Target Price
High Target Price
Mean Target Price
Low Target Price
Median Target Price
Earnings Estimates
| Current Qtr12/2024 | Next Qtr03/2025 | Fiscal Yr12/2024 | Fiscal Yr12/2025 | |
|---|---|---|---|---|
| Average Estimate | -0.07 | 1.50 | -1.30 | 2.99 |
| Number of Estimates | 1 | 1 | 1 | 1 |
| High Estimate | -0.07 | 1.50 | -1.30 | 2.99 |
| Low Estimate | -0.07 | 1.50 | -1.30 | 2.99 |
| Prior Year | -0.77 | 0.59 | -6.23 | -1.30 |
| Growth Rate Est. (year over year) | +90.91% | +154.24% | +79.13% | +330.00% |
Earnings History - Surprises*
| Qtr Ending09/2024 | Qtr Ending06/2024 | Qtr Ending03/2024 | Qtr Ending12/2023 | |
|---|---|---|---|---|
| Reported | $1.37 | $-2.32 | $0.59 | $-0.77 |
| Estimate | $0.49 | $-0.97 | N/A | $-0.33 |
| Difference | +0.88 | -1.35 | N/A | -0.44 |
| Surprise | +179.59% | -139.18% | N/A | -133.33% |
* Earnings are based on GAAP income from continuing operations.
Average Analyst Ratings
Rating
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell
# of Analysts
3.00
3 Mths Ago2
3.67
2 Mths Ago3
3.67
1 Mth Ago3
3.67
Current3
Ratings Values:
Strong Buy5
Moderate Buy4
Hold3
Moderate Sell2
Strong Sell1
Ratings Breakdown
| 3 Mths Ago | 2 Mths Ago | 1 Mth Ago | Current | |
|---|---|---|---|---|
| # of Analysts: | 2 | 3 | 3 | 3 |
1 | 2 | 2 | 2 | |
| Holds | 0 | 0 | 0 | 0 |
1 | 1 | 1 | 1 |
Key:
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell